Nov 19, 2024 9:15am EST FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
Nov 14, 2024 9:15am EST FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
Nov 12, 2024 4:20pm EST FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Oct 29, 2024 9:15am EDT FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
Oct 28, 2024 9:31am EDT FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
Oct 18, 2024 8:30am EDT FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
Oct 16, 2024 9:15am EDT FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
Oct 11, 2024 9:31am EDT FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit